The cholera risk assessment in Kano State, Nigeria: A historical review, mapping of hotspots and evaluation of contextual factors.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
01 2021
Historique:
received: 12 06 2020
accepted: 07 12 2020
revised: 29 01 2021
pubmed: 20 1 2021
medline: 7 5 2021
entrez: 19 1 2021
Statut: epublish

Résumé

Nigeria is endemic for cholera since 1970, and Kano State report outbreaks annually with high case fatality ratios ranging from 4.98%/2010 to 5.10%/2018 over the last decade. However, interventions focused on cholera prevention and control have been hampered by a lack of understanding of hotspot Local Government Areas (LGAs) that trigger and sustain yearly outbreaks. The goal of this study was to identify and categorize cholera hotspots in Kano State to inform a national plan for disease control and elimination in the State. We obtained LGA level confirmed and suspected cholera data from 2010 to 2019 from the Nigeria Centre for Disease Control (NCDC) and Kano State Ministry of Health. Data on inland waterbodies and population numbers were obtained from online sources and NCDC, respectively. Clusters (hotspots) were identified using SaTScan through a retrospective analysis of the data for the ten-year period using a Poisson discrete space-time scan statistic. We also used a method newly proposed by the Global Task Force on Cholera Control (GTFCC) to identify and rank hotspots based on two epidemiological indicators including mean annual incidence per 100 000 population of reported cases and the persistence of cholera for the study period. In the ten-year period, 16,461 cholera cases were reported with a case fatality ratio of 3.32% and a mean annual incidence rate of 13.4 cases per 100 000 population. Between 2010 and 2019, the most severe cholera exacerbations occurred in 2014 and 2018 with annual incidence rates of 58.01 and 21.52 cases per 100 000 inhabitants, respectively. Compared to 2017, reported cases and deaths increased by 214.56% and 406.67% in 2018. The geographic distribution of outbreaks revealed considerable spatial heterogeneity with the widest in 2014. Space-time clustering analysis identified 18 out of 44 LGAs as high risk for cholera (hotspots) involving both urban and rural LGAs. Cholera clustered around water bodies, and the relative risk of having cholera inside the hotspot LGA were 1.02 to 3.30 times higher than elsewhere in the State. A total of 4,894,144 inhabitants were in these hotspots LGAs. Of these, six LGAs with a total population of 1.665 million had a relative risk greater than 2 compared to the state as a whole. The SaTScan (statistical) and GTFCC methods were in agreement in hotspots identification. This study identified cholera hotspots LGAs in Kano State from 2010-2019. Hotspots appeared in both urban and rural settings. Focusing control strategies on these hotspots will facilitate control and eliminate cholera from the State.

Identifiants

pubmed: 33465091
doi: 10.1371/journal.pntd.0009046
pii: PNTD-D-20-01045
pmc: PMC7846125
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009046

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI123422
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI175214
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006118
pubmed: 29284003
J Water Health. 2003 Mar;1(1):45-52
pubmed: 15384272
Emerg Infect Dis. 2008 May;14(5):798-800
pubmed: 18439365
PLoS Negl Trop Dis. 2020 Apr 15;14(4):e0008227
pubmed: 32294084
PLoS One. 2016 Aug 01;11(8):e0159794
pubmed: 27479360
Microbes Infect. 2002 Feb;4(2):237-45
pubmed: 11880057
Wkly Epidemiol Rec. 2016 Sep 23;91(38):433-40
pubmed: 27665620
Emerg Infect Dis. 2011 Nov;17(11):2026-34
pubmed: 22099090
PLoS Med. 2005 Mar;2(3):e59
pubmed: 15719066
PLoS Negl Trop Dis. 2016 Nov 17;10(11):e0005105
pubmed: 27855171
PLoS One. 2015 Oct 13;10(10):e0140021
pubmed: 26461923
Am J Trop Med Hyg. 2018 May;98(5):1269-1274
pubmed: 29512484
Int J Health Geogr. 2008 Dec 16;7:62
pubmed: 19087235
BMC Res Notes. 2019 Oct 21;12(1):664
pubmed: 31639037
Pan Afr Med J. 2012;12:59
pubmed: 22937199
Wkly Epidemiol Rec. ;92(36):521-30
pubmed: 28884993
Emerg Infect Dis. 2019 May;25(5):856-864
pubmed: 31002075
Wkly Epidemiol Rec. 2015 Oct 2;90(40):517-28
pubmed: 26433979
Cent Afr J Med. 2005 Mar-Apr;51(3-4):34-8
pubmed: 17892230
PLoS Negl Trop Dis. 2017 Mar 13;11(3):e0005407
pubmed: 28288154
Health Place. 2014 Jan;25:47-55
pubmed: 24239703
Health Place. 2015 Jul;34:107-17
pubmed: 25997026
PLoS Negl Trop Dis. 2015 Jun 04;9(6):e0003832
pubmed: 26043000
PLoS One. 2015 Aug 18;10(8):e0135676
pubmed: 26284367
Acta Trop. 2019 Feb;190:235-243
pubmed: 30465744

Auteurs

Moise Chi Ngwa (MC)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Chikwe Ihekweazu (C)

Nigeria Centre for Disease Control, Abuja, Nigeria.

Tochi Okwor (T)

Nigeria Centre for Disease Control, Abuja, Nigeria.

Sebastian Yennan (S)

Nigeria Centre for Disease Control, Abuja, Nigeria.

Nanpring Williams (N)

Nigeria Centre for Disease Control, Abuja, Nigeria.

Kelly Elimian (K)

Department of Microbiology, University of Benin, Nigeria.

Nura Yahaya Karaye (NY)

Department of Public Health and Disease Control, Kano State Ministry of Health, Kano, Nigeria.

Imam Wada Bello (IW)

Department of Public Health and Disease Control, Ministry of Health Kano, Kano, Nigeria.

David A Sack (DA)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH